Canlyniadau Chwilio - Gabriel E. DiMattia

  • Dangos 1 - 17 canlyniadau o 17
Mireinio'r Canlyniadau
  1. 1
    Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.

    Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. gan Birgit Gellersen, Rita Kempf, Ralph Telgmann, Gabriel E. DiMattia

    Cyhoeddwyd 1994
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line.

    Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. gan Gabriel E. DiMattia, Birgit Gellersen, Mary Lynn Duckworth, Henry G. Friesen

    Cyhoeddwyd 1990
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Spatiotemporal analysis of ratiometric biosensors in live multicellular spheroids using SPoRTS

    Spatiotemporal analysis of ratiometric biosensors in live multicellular spheroids using SPoRTS gan Matthew J. Borrelli, Bart Kolendowski, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids

    Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids gan Rohann Correa, Teresa Peart, Yudith Ramos Valdés, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities

    Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities gan Bart Kolendowski, Shifa Cheng, Yudith Ramos Valdés, Trevor G. Shepherd, Gabriel E. DiMattia

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy

    A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy gan James I. MacDonald, Yudith Ramos-Valdes, Pirunthan Perampalam, Larisa Litovchick, Gabriel E. DiMattia, Frederick A. Dick

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis

    Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis gan Emily Tomas, Yudith Ramos Valdés, Jennifer S. Davis, Bart Kolendowski, Adrian Buensuceso, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    GERp95, a Membrane-associated Protein that Belongs to a Family of Proteins Involved in Stem Cell Differentiation

    GERp95, a Membrane-associated Protein that Belongs to a Family of Proteins Involved in Stem Cell Differentiation gan Darren E. Cikaluk, Nasser Tahbaz, L C Hendricks, Gabriel E. DiMattia, Dave Hansen, David B. Pilgrim, Tom C. Hobman

    Cyhoeddwyd 1999
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer

    Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer gan James Greenaway, Carl Virtanen, Kata Osz, Tamás Révay, Daniel B. Hardy, Trevor G. Shepherd, Gabriel E. DiMattia, Jim Petrik

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids

    TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids gan Samah Rafehi, Yudith Ramos Valdés, Monique Bertrand, Jacob McGee, Michel Préfontaine, Akira Sugimoto, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

    Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential gan Jessica Tong, Yudith Ramos Valdés, Milani Sivapragasam, John W. Barrett, John C. Bell, David F. Stojdl, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene.

    A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. gan Simon J. Rhodes, Renjie Chen, Gabriel E. DiMattia, Kathleen M. Scully, K A Kalla, Shih‐Hung Lin, Victor C. Yu, M G Rosenfeld

    Cyhoeddwyd 1993
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1

    Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1 gan Gregory J. Block, Shinya Ohkouchi, France W. Fung, Joshua Frenkel, Carl A. Gregory, Radhika Pochampally, Gabriel E. DiMattia, Deborah E. Sullivan, Darwin J. Prockop

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids

    Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids gan Teresa Peart, Yudith Ramos Valdés, Rohann Correa, Elena N. Fazio, Monique Bertrand, Jacob McGee, Michel Préfontaine, Akira Sugimoto, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

    Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability gan Rohann Correa, Yudith Ramos Valdés, Teresa Peart, Elena N. Fazio, Monique Bertrand, Jacob McGee, Michel Préfontaine, Akira Sugimoto, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis

    Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis gan Jessica Tong, Yudith Ramos Valdés, John W. Barrett, John C. Bell, David F. Stojdl, Grant McFadden, J. Andrea McCart, Gabriel E. DiMattia, Trevor G. Shepherd

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target

    Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target gan Marta Llauradó Fernández, Amy Dawson, Joshua Hoenisch, Hannah Kim, Sylvia Bamford, Clara Salamanca, Gabriel E. DiMattia, Trevor G. Shepherd, Mattia Cremona, Bryan T. Hennessy, Shawn Anderson, Stanislav Volik, Colin C. Collins, David G. Huntsman, Mark Carey

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: